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Interactions between bacterial and fungal cells shape many polymicrobial communities. 1 
Bacteria elaborate diverse strategies to interact and compete with other organisms, including 2 
the deployment of protein secretion systems. The Type VI secretion system (T6SS) delivers toxic 3 
effector proteins into host eukaryotic cells and competitor bacterial cells. Yet surprisingly, 4 
T6SS-delivered effectors targeting fungal cells have not been reported. Here we show that the 5 
‘anti-bacterial’ T6SS of Serratia marcescens can act against fungal cells, including pathogenic 6 
Candida species, and identify the novel effector proteins responsible. These first anti-fungal 7 
effectors, Tfe1 and Tfe2, have distinct and species-specific impacts on the target cell, but both 8 
can ultimately cause fungal cell death. ‘In competition’ proteomics analysis revealed that T6SS-9 
mediated delivery of Tfe2 disrupts nutrient uptake and amino acid metabolism in fungal cells, 10 
and leads to the induction of autophagy. Intoxication by Tfe1, in contrast, causes a loss of 11 
plasma membrane potential. Our findings extend the repertoire of the T6SS and suggest that 12 
anti-fungal T6SSs represent widespread and important determinants of the outcome of 13 
bacterial-fungal interactions. 14 
 15 
Bacteria and fungi frequently cohabit in a multitude of different environments, from abiotic 16 
surroundings, such as soil, to plant and mammalian hosts, including polymicrobial infection sites. 17 
Bacteria may develop strategies to profit from the metabolic activity of neighbouring fungal cells, for 18 
example utilising fungal breakdown products from otherwise inaccessible organic material. 19 
Conversely, they may elaborate antagonistic strategies to contain growth of competing microbes, such 20 
as efficient scavenging of scarce nutrients or direct attack upon the competitor1, 2. Gram-negative 21 
bacteria utilise complex transport machineries, protein secretion systems, to translocate effector 22 
proteins into other cells3. Following translocation, the bacterial effector destroys or reprogrammes the 23 
target cell for the benefit of the secreting bacterium. The Type VI secretion system (T6SS) is a 24 
widespread, bacteriophage-like machinery that fires toxic effectors into neighbouring cells. It uses a 25 
tubular contractile sheath to expel a cell-puncturing structure, decorated with a variety of effector 26 
proteins, out of the bacterial cell towards the target 4-6. Some of these effectors are deployed against 27 
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higher eukaryotes, representing classical anti-host virulence factors7. Nevertheless, recent findings 1 
indicate that the function of most T6SSs is to deliver anti-bacterial toxins into rival bacterial cells, 2 
providing a competitive advantage in mixed bacterial populations. These T6SS-delivered anti-3 
bacterial effectors, including toxins targeting the bacterial cell wall, cell membrane and nucleic acids, 4 
are each associated with a specific immunity protein to protect the secreting cell and its siblings from 5 
self-intoxication8, 9. Surprisingly, however, given the close association of bacteria and fungi in many 6 
environments, no anti-fungal effectors delivered by the T6SS have been reported to date.  7 
  8 
Results 9 
The anti-bacterial T6SS of Serratia marcescens displays anti-fungal activity 10 
To investigate whether the bacterial T6SS could affect proliferation of eukaryotic microorganisms 11 
commonly encountered in microbial communities, the ubiquitous yeast Saccharomyces cerevisiae was 12 
used as a model target organism. Serratia marcescens Db10, which possesses a well-characterised and 13 
potent anti-bacterial T6SS10, was utilised as the bacterial ‘attacker’. Co-culture of these two organisms 14 
resulted in >100-fold decrease of recovered viable yeast cells, indicating that S. marcescens, itself a 15 
ubiquitous microorganism, can restrict fungal proliferation in mixed microbial cultures (Fig. 1a). 16 
When co-cultures were performed using S. marcescens ∆tssE, a T6SS-inactive mutant, recovery of 17 
viable fungal cells was unaffected, demonstrating that the observed inhibition is T6SS-dependent 18 
(Fig. 1a). Direct translocation of effector proteins into a target cell requires the T6SS to puncture and 19 
traverse the target cell wall. Considering the thickness and rigidity of the fungal cell wall11 and that 20 
the S. marcescens T6SS readily releases secreted proteins to the extracellular medium12, we 21 
considered that anti-fungal toxins might instead be secreted into the external milieu with subsequent 22 
uptake by the fungal cell. When the assay was repeated with bacterial and fungal cells separated by a 23 
cell-impermeable membrane, the number of recovered fungal cells was independent of the T6SS 24 
functionality of the underlying bacterial strain and comparable to that when placed directly on the 25 
media (Fig. 1a). Thus bacterial-fungal cell contact is essential for anti-fungal T6SS activity. Next, the 26 
range of fungal target cells was expanded to include pathogenic fungi, namely Candida species, 27 
clinically-important fungal pathogens commonly residing with bacteria in polymicrobial infection 28 
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sites2, 13. We tested Candida albicans, the most frequently-isolated fungal pathogen in humans, and 1 
the phylogenetically-distant Candida glabrata, which displays intrinsic resistance to common anti-2 
fungal drugs14. Both organisms were susceptible to T6SS-mediated anti-fungal activity, indicating a 3 
broad anti-fungal action of the S. marcescens T6SS (Fig. 1b).  4 
 5 
Identification of two anti-fungal T6SS effector proteins 6 
Having established fungi as a new target kingdom of the S. marcescens T6SS, we sought to identify 7 
the effector proteins responsible. The potential anti-fungal activity of six previously-identified T6SS-8 
secreted proteins (Ssp1-612) was tested by utilising specific effector deletion mutants as attacker 9 
strains. Deletion of SMDB11_1112 (ssp3) resulted in a 4-fold increase in recovery of viable C. 10 
albicans target cells compared with the wild type, although it had little effect on S. cerevisiae or C. 11 
glabrata (Fig. 1c). SMDB11_1112 was therefore renamed Tfe1 (T6SS anti-fungal effector 1). 12 
Subsequent deletion of five more effectors (mutant ∆ssp1-6) had no additional effect on the survival 13 
of fungal cells (Supplementary Fig. 1), suggesting the existence of further, unidentified T6SS-14 
dependent effector(s). 15 
To identify additional potential effectors, we employed a cellular proteomics approach, a 16 
complementary strategy to our previous secretome analysis, with the rationale that T6SS-secreted 17 
proteins would be retained inside the cell of a T6SS-inactive mutant. Using label-free quantitative 18 
mass spectrometry, we quantified 3034 proteins, representing 64% of the S. marcescens Db10 19 
genome. Twelve proteins were identified as having significantly increased intracellular abundance in 20 
the ∆tssE mutant compared with the wild type (Fig. 2a, Supplementary Data 1, Supplementary Fig. 2). 21 
Nine were known secreted components or effectors of the T6SS machinery12, 15, including Tfe1, 22 
validating the approach. The remaining three proteins, of unknown functions, represented new T6SS-23 
secreted effector candidates. Since, as a predicted lipoprotein, SMDB11_1031 is unlikely to be 24 
available for T6SS-dependent secretion, we focused on the two remaining candidates, SMDB11_1083 25 
and SMDB11_3457, the latter encoded downstream of two Hcp homologues. Neither candidate is 26 
encoded adjacent to potential cognate immunity proteins (Fig. 2b). This non-compliance with one of 27 
the main criteria for anti-bacterial effectors8 further marked them as potential anti-fungal agents.  28 
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To determine whether SMDB11_1083 or SMDB11_3457 are T6SS-delivered anti-fungal toxins, the 1 
respective deletion mutants were used as attacking strains in bacterial-fungal co-cultures. Whereas 2 
loss of SMDB11_3457 did not have any effect on anti-fungal activity of S. marcescens, removal of 3 
SMDB11_1083 resulted in almost complete loss of activity against S. cerevisiae or C. glabrata and 4 
reduced activity against C. albicans (Fig. 1c). SMDB11_1083 therefore represents a second T6SS-5 
delivered anti-fungal effector, named Tfe2. When C. albicans was co-cultured with a mutant lacking 6 
Tfe1 and Tfe2, the partial anti-fungal activity seen with either single mutant was eliminated. 7 
Expression of Tfe1 and Tfe2 in trans was able to restore fungal inhibition in the respective deletion 8 
mutants (Fig. 1d). Overexpression of Tfe1 decreased anti-fungal activity against S. cerevisiae and C. 9 
glabrata, perhaps indicating that competition between Tfe1 and Tfe2 for the T6SS machinery resulted 10 
in reduced delivery of the more potent Tfe2. Finally, confirming that Tfe1 and Tfe2 are not required 11 
for T6SS function, mutants lacking Tfe1 and Tfe2 had no impairment in their ability to secrete the 12 
expelled component Hcp or the effector Ssp2 (Fig. 1e), or in anti-bacterial activity against 13 
Pseudomonas fluorescens (Supplementary Fig. 3).  14 
Tfe1 can induce mild growth inhibition if overexpressed in bacterial cells, which is alleviated by co-15 
expression with the immunity protein Sip312. However, in contrast to mutants lacking immunity 16 
proteins for true anti-bacterial effectors12, 15, 16, the ∆sip3 mutant is fully fit and is not sensitive to the 17 
T6SS of the wild type or a Tfe1-overexpressing strain (Supplementary Fig. 3). These data suggest that 18 
the intended target of Tfe1 is not bacterial cells, but that Sip3 acts as a failsafe against non-specific 19 
toxicity should excess Tfe1 occur. For Tfe2, no anti-bacterial toxicity could be detected upon 20 
overexpression nor candidate immunity gene identified. Additionally, the S. marcescens T6SS, and by 21 
implication its effectors, does not appear to act against higher eukaryotic organisms, since T6SS-22 
inactive mutants show no loss of virulence in several models (ref17, Supplementary Fig. 4). Taken 23 
together, we conclude that Tfe1 and Tfe2 are the major anti-fungal toxins deployed by the T6SS of S. 24 
marcescens and are likely to be used only against fungal cells.  25 
 26 
Tfe1 and Tfe2 exhibit distinct and target-specific anti-fungal activity 27 
Bioinformatic analysis failed to reveal conserved domains or predicted functions for Tfe1 or Tfe2. 28 
6 
 
Therefore their impact on fungal cell integrity was investigated following growth in co-culture with S. 1 
marcescens. With C. albicans as the target, cell distortion and lysis was detected, dependent on the 2 
T6SS and Tfe1 in the attacking bacteria (Fig. 3a). Consistently, many necrotic C. albicans cells were 3 
observed by cryo-TEM following co-culture with wild type S. marcescens, whereas few such cells 4 
were seen with a T6SS-inactive mutant (Supplementary Fig. 5). With S. cerevisiae or C. glabrata, 5 
granular structures were observed in a T6SS- and Tfe2-dependent manner (Fig. 3a), consistent with 6 
the primary role of Tfe2 against both organisms in co-culture viability assays (Fig. 1). Propidium 7 
iodide (PI) stains cells which have lost the membrane permeability barrier, a common indirect proxy 8 
for loss of viability. We observed that ~50% of C. albicans and C. glabrata cells recovered from co-9 
cultures with S. marcescens showed PI-staining, dependent on the T6SS and either Tfe1 (C. albicans) 10 
or Tfe2 (C. glabrata) (Fig. 3b). These observations are consistent with co-culture viable count assays 11 
(Fig. 1), where recovery of viable fungal cells co-cultured with wild type S. marcescens was lower 12 
than the initial inoculum, implying fungicidal action. In contrast, PI-staining was not observed in S. 13 
cerevisiae.  To confirm directly that Tfe1 and Tfe2 possess intrinsic anti-fungal activity, and 14 
investigate further their impact on the different fungal species, each effector was expressed in S. 15 
cerevisiae and C. albicans using galactose- and doxycycline-inducible18 expression systems, 16 
respectively. Expression of Tfe1, but not the anti-bacterial effectors Ssp1 and Ssp2, strongly inhibited 17 
growth of S. cerevisiae and induced abnormally large vacuoles and cell lysis (Fig. 3d,e; 18 
Supplementary Fig. 6), confirming the fungicidal potential of Tfe1. Similarly, expression of Tfe1 in 19 
C. albicans caused growth inhibition and cell death (Supplementary Fig. 7) and reproduced the Tfe1-20 
dependent morphological changes observed in co-culture (Fig.3c). Expression of Tfe2 in S. 21 
cerevisiae, whilst not causing obvious changes in morphology, was able to abolish growth, even at 22 
very low levels (Fig. 3c,d). 23 
Induction of Tfe2 during logarithmic growth of S. cerevisiae in liquid cultures resulted in a decline in 24 
the number of viable cells over time, whilst cell density approached steady-state. Upon removal of 25 
induction, yeast cells recovered from Tfe2-induced growth inhibition within 3 h to resume normal 26 
growth (Fig. 4a). These results indicate that Tfe2-mediated intoxication of S. cerevisiae primarily 27 
results in growth inhibition, with reduced long-term survival as a downstream consequence. To 28 
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investigate whether the fungistatic effect of Tfe2 on S. cerevisiae was caused by inhibition of 1 
metabolic activity, the fluorescent dye FUN1 was utilised. Metabolically-active cells transport the dye 2 
into the vacuole where it forms distinct tubular structures which exhibit red fluorescence. In 3 
metabolically-inactive cells, the dye remains in the cytoplasm and fluoresces green19. Bright red 4 
structures, apparently vacuole-associated and similar to those observed in the control strain, were 5 
detected during early stages of Tfe1 expression when the cells gained dramatically in size (Fig. 4b), 6 
eventually being replaced by green fluorescence before onset of lysis. Tfe2-expressing cells also 7 
displayed bright red fluorescent structures, however, these appeared more globular, dispersed and 8 
mainly outside the vacuole. Together with the persistence of green fluorescence, this indicates that 9 
Tfe2 causes reduced cellular metabolic activity and potential interference with vacuolar transport20.  10 
To determine whether either effector causes loss of plasma membrane potential, S. cerevisiae cells 11 
expressing Tfe1 or Tfe2 were stained with the voltage-dependent dye DiBAC4(3) which enters cells in 12 
a depolarisation-dependent manner. Tfe1 intoxication resulted in membrane depolarisation, similar to 13 
treatment with mellitin and amphotericin B, whereas Tfe2 caused no loss of membrane potential (Fig. 14 
4c). Co-staining with PI revealed that only a fraction of the Tfe1-intoxicated cells showing 15 
depolarisation also exhibited a loss of membrane integrity, in contrast with the action of the pore-16 
forming peptide mellitin where all depolarised cells were also permeabilised (Fig. 4d, Supplementary 17 
Fig. 8). Intoxication of C. albicans by T6SS-delivered Tfe1 caused a similar pattern of membrane 18 
depolarisation and selective permeability (Supplementary Fig. 9). Thus our data suggest that Tfe1 19 
primarily causes a loss of membrane potential, which is not due to pore formation but can ultimately 20 
lead to a loss of membrane integrity, and imply that Tfe1 and Tfe2 act on different cellular targets in 21 
fungal cells.  22 
 23 
The T6SS can act on filamentous fungal cells 24 
Whilst P. aeruginosa has been reported to preferentially kill the hyphal form of C. albicans21, we had 25 
so far demonstrated T6SS activity against the budding yeast form. Co-culture of S. marcescens with 26 
the constitutively filamentous tup1Δ mutant22 revealed PI-staining of individual cell segments within 27 
filaments, with this localised action being dependent on the T6SS and Tfe1 (Fig. 4e,f). A T6SS- and 28 
8 
 
Tfe1-dependent drop in viable cell counts was also observed (Supplementary Fig. 10). Thus the anti-1 
fungal S. marcescens T6SS can intoxicate budding and filamentous forms of C. albicans. 2 
 3 
‘In competition’ proteomics reveals that T6SS-delivered Tfe2 disrupts nutrient transport and 4 
metabolism and induces autophagy 5 
To identify specific cellular pathways affected by the anti-fungal effectors in a physiologically-6 
relevant context, namely when delivered by the T6SS, we performed ‘in competition’ proteomics 7 
using C. albicans as target. Fungal cells were co-cultured with wild type S. marcescens Db10, the 8 
T6SS-inactive mutant ∆tssE, or effector mutants, ∆tfe1, ∆tfe2 and ∆tfe1∆tfe2, before performing 9 
quantitative mass spectrometric analysis of the total fungal proteome in each condition using isotope-10 
labelled tandem mass tags (six-plex TMT). 4446 C. albicans proteins (~72% of the genome) and 2486 11 
S. marcescens proteins were quantified (Supplementary Data 2, Supplementary Fig. 11-15). Of the C. 12 
albicans proteins, 1667 showed significant modulation across the five-way comparison (ANOVA-13 
positive, p<0.05). Hierarchical clustering of these modulated proteins confirmed that Tfe1 and Tfe2 14 
cause disruption of different fungal pathways. The analysis also demonstrated that the major response 15 
of C. albicans is to T6SS-dependent translocation of Tfe2, since the response to the ∆tfe2 mutant was 16 
similar to that of ∆tssE or ∆tfe1∆tfe2 (Fig. 5a). To identify individual proteins within this set as being 17 
robustly altered in specific response to Tfe2, we further imposed requirements for a significant change 18 
in abundance (>1.3-fold) to be observed in the presence of the wild type compared with the ∆tfe2 19 
mutant, and for a consistent change to be observed in ∆tfe1∆tfe2 and ∆tssE mutants. According to 20 
these criteria, 14 fungal proteins were upregulated in response to Tfe2 delivery and 16 downregulated 21 
(Supplementary Table 1). In contrast, no Tfe1-specific proteins were identified using these strict 22 
criteria. This may, at least in part, reflect Tfe1 acting on a non-protein target, consistent with its ability 23 
to induce plasma membrane depolarisation. Evaluation of the 30 Tfe2-responsive proteins by Gene 24 
Ontology enrichment analysis identified significant overrepresentation of proteins belonging to the 25 
cellular amino acid biosynthetic process (GOID 8652), specifically arginine biosynthesis (GOID 26 
6526) and sulfur amino acid biosynthesis (GOID 0097), as well as anion transport (GOID 6820) (Fig. 27 
5b; see also Supplementary Fig. 16). Therefore subsequent analysis was focused on these areas of 28 
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nutrient uptake and amino acid metabolism. 1 
Fungal cells must acquire sulfur from their environment for the de novo biosynthesis of cysteine, 2 
methionine and other organic sulfur metabolites, such as glutathione23. The sole sulfate transporter in 3 
C. albicans, Sul2, and members of the sulfate assimilation pathway were strongly decreased in the 4 
presence of Tfe2-translocating bacteria. Heat map analysis of relevant proteins revealed 5 
downregulation of the entire pathway for reduction of inorganic sulfate to homocysteine in response 6 
to Tfe2 (Fig. 5c). Similar to Sul2, two general amino acid permeases, Gap1 and Gap2, and two basic 7 
amino acid permeases, Can1 and Can2, all of which transport arginine into the fungal cell24-26, were 8 
subject to Tfe2-dependent downregulation (Fig. 5d). Furthermore, examination of arginine metabolic 9 
proteins27 in the proteomics dataset indicated Tfe2-dependent accumulation of proteins involved in 10 
arginine synthesis, whereas proteins mediating arginine catabolism were unchanged or decreased (Fig. 11 
5d). Consistent with this profile, intracellular arginine levels in S. cerevisiae expressing Tfe2 were 12 
increased 4-fold compared with control cells (Fig. 6a). Lysine levels were also increased, and a 13 
further 14 amino acids displayed a range of down- or upregulation, indicating extensive nutrient 14 
imbalance upon Tfe2-mediated intoxication. 15 
Next, we determined if Tfe2-induced reduction of fungal nutrient transporters, which also included 16 
the peptide transporter Ptr22 (Supplemental Table 1), is due to transcriptional downregulation. Plasma 17 
membrane transporter expression is induced by substrate, which is sensed by the transporter itself, as 18 
for Sul2, or by non-transporting membrane proteins, including the amino acid sensor Csy1 (Ssy1 in S. 19 
cerevisiae), a component of the SPS sensing complex28, 29. Transcript levels of the sensor gene SSY1, 20 
SPS-activated transcriptional regulators STP1 and STP2, and SPS-controlled permease genes30-32 were 21 
increased upon expression of Tfe2 in S. cerevisiae (Fig. 6b). This implies that Tfe2 does not inhibit 22 
SPS sensing or signalling. Rather, transcriptional induction of the SPS-regulon is consistent with 23 
Tfe2-induced intracellular nutrient depletion or imbalance. Similarly, sulfate transporter transcript 24 
levels were upregulated by Tfe2, despite downregulation at the protein level. We confirmed that 25 
T6SS-mediated delivery of Tfe2 decreases levels of Can1 in S. cerevisiae, with redistribution from the 26 
plasma membrane suggesting vacuolar degradation (Supplementary Fig. 17). These data indicate that 27 
Tfe2 intoxication causes depletion of nutrient transporters at a post-transcriptional level. In turn, the 28 
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resulting decrease in intracellular nutrients may lead to downregulation of nutrient-utilisation 1 
pathways, as observed for proteins of the sulfate assimilation pathway (Fig. 5c), or in upregulation of 2 
compensatory metabolic pathways, as observed for arginine synthesis (Fig. 5d). 3 
Further evidence for Tfe2-dependent interference with the intracellular amino acid pool was the 4 
marked increase in the bZip transcriptional activator protein Gcn4 (Supplemental Table 1), which 5 
mediates the general amino acid control (GAAC) response to amino acid starvation33, 34. The 6 
proteomics data also revealed a Tfe2-dependent increase in the levels of Atg1, a Ser/Thr kinase 7 
subject to regulation by the nutrient-sensing TOR signalling pathway. Activation of Atg1 by 8 
phosphorylation in response to nitrogen and amino acid starvation leads to induction of autophagy35. 9 
To investigate if Tfe2-mediated amino acid limitation leads to autophagy, we analysed proteolytic 10 
processing of the autophagy reporter protein GFP-Atg836, 37 in S. cerevisiae co-cultured with S. 11 
marcescens. With yeast alone, only full length GFP-Atg8 was observed. Upon co-culture with wild 12 
type S. marcescens, a band corresponding to free GFP was detected, indicating processing of GFP-13 
Atg8 by vacuolar peptidases and thus induction of autophagy. Processing was not detected upon co-14 
culture with bacteria lacking Tfe2 or a functional T6SS, nor in cells lacking the key autophagy 15 
regulator, Atg13 (Fig. 6c, Supplementary Fig. 18). Hence induction of autophagy is dependent on 16 
T6SS-mediated delivery of Tfe2. Although Tfe2 may induce autophagy independent of amino acid 17 
imbalance, our results are consistent with the idea that Tfe2-mediated intoxication of fungal cells 18 
leads to disruption of the intracellular amino acid pool, causing a starvation signal which induces 19 
autophagy as a protective response.  20 
Overall, we have revealed that Tfe2 intoxication leads to extensive nutrient imbalance, interference 21 
with plasma membrane transporters and induction of autophagy. The precise aspect or combination of 22 
these factors which ultimately leads to the death of the fungal cell remains to be deciphered. In 23 
contrast, Tfe1 acts via a plasma membrane depolarising mechanism which does not involve formation 24 
of large, unselective pores. 25 
  26 
Discussion 27 
Cellular proteomics combined with genetic analysis led us to discover the first T6SS-dependent anti-28 
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fungal effectors, Tfe1 and Tfe2, whose T6SS-dependent secretion was confirmed in our concurrent 1 
secretome study15. The two effectors elicit distinct responses in fungal cells and can exert a fungicidal 2 
effect. The severity of the fungal response to each toxin differs between species, likely reflecting 3 
divergence of metabolic pathways. ‘In competition’ proteomics revealed that T6SS-delivered Tfe2 4 
disrupts fungal nutrient uptake and metabolism. In particular, Tfe2 intoxication strongly affected 5 
inter-related pathways involved in sulfate assimilation, plasma membrane nutrient transport and 6 
amino acid metabolism and also caused induction of autophagy. Autophagy is a process by which, 7 
under nutrient-limiting stress conditions, fungal cells target cellular macromolecules for vacuolar 8 
degradation and recycling35, 38. Induction of this pathway in response to Tfe2 indicates severe 9 
disturbance of the intracellular metabolic equilibrium and may represent a protective response 10 
attempting to rescue the viability of the fungal cell. A striking change in response to Tfe2 was 11 
increased intracellular levels of arginine and lysine. Upregulation of arginine and lysine synthesis has 12 
been linked to sudden nutrient limitation upon engulfment by neutrophils39, 40, and regulation of 13 
arginine synthesis in response to phagocytosis may also represent a protective mechanism against the 14 
phagocyte oxidative burst in C. albicans 41, 42. Thus Tfe2 may be causing a similar response to that 15 
induced upon phagocytosis. Tfe1, in contrast, does not provoke a strong proteomic response and 16 
instead causes plasma membrane depolarisation, reminiscent of T6SS-delivered antibacterial effectors 17 
which target the bacterial membrane8. 18 
This study demonstrates that the bacterial T6SS can act as a potent anti-fungal weapon, causing 19 
growth arrest and death of fungal cells. In agreement with the prevailing model, T6SS-dependent anti-20 
fungal activity required attacker-target cell-cell contact, suggesting that effector translocation occurs 21 
directly into the fungal cell. Supporting the feasibility of this idea, cryo-TEM showed an intimate 22 
interaction between cells of C. albicans and S. marcescens (Supplementary Fig. 5). Moreover, the 23 
expelled arrow-like structure of the T6SS should have both the length (approximately 0.7 µm, at least 24 
three times the thickness of the average fungal cell wall)43-45 and the force4 to puncture the rigid 25 
fungal cell wall. The S. marcescens T6SS delivers multiple anti-bacterial effectors and is a potent 26 
weapon against competitor bacteria15, 17. However this study reveals a second, prominent role for this 27 
T6SS in controlling growth of co-habiting fungal micro-organisms. Whilst Serratia-Candida 28 
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interactions may on occasion be relevant clinically, given that both can colonise common sites such as 1 
bloodstream, respiratory, and GI tracts2, 46, 47, Serratia is ubiquitous in the environment and likely uses 2 
its anti-fungal T6SS in diverse contexts. More importantly, our work implies that other bacterial 3 
pathogens may deploy a T6SS against fungal cells during polymicrobial infection. This is supported 4 
by the observation that Tfe2 homologues are present in other pathogenic T6SS-containing bacteria, 5 
including Pseudomonas and Vibrio species. Thus, we propose that anti-fungal T6SS activity is 6 
widespread and may be an intrinsic property of many, if not all, ‘anti-bacterial’ T6SSs. Indeed, one 7 
report has suggested anti-yeast activity associated with a T6SS in P. syringae, although no effectors 8 
were identified48. The fact that T6SS anti-fungal effectors have not been discovered previously may 9 
be partially attributable to many identification strategies relying on the presence of associated 10 
immunity proteins, therefore excluding proteins such as Tfe2.  11 
With the identification of a new class of effectors, anti-fungal toxins, we have expanded the repertoire 12 
of the T6SS arsenal to include another target kingdom and highlighted another role for this versatile 13 
machinery in shaping polymicrobial communities. Deployment of T6SSs enabling simultaneous 14 
attack upon prokaryotic and fungal rivals should represent a key determinant of bacterial competitive 15 
fitness in a multitude of environments, from rhizosphere to polymicrobial human infections.  16 
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Methods 1 
Bacterial strains, plasmids and culture conditions 2 
Bacterial strains and plasmids used in this study are given in Supplementary Table 2. Mutant strains 3 
of S. marcescens Db10 carrying in-frame deletions were generated by allelic exchange using the 4 
pKNG101 suicide vector, and effector genes were cloned into pSUPROM for constitutive expression 5 
in trans10. To avoid non-specific anti-bacterial toxicity upon complementation of the Δtfe1 strain by 6 
plasmid-encoded Tfe1, the cognate immunity gene sip3 was included in the construct. All primer 7 
sequences for mutant and plasmid generation are given in Supplementary Table 3. Strains of S. 8 
marcescens were grown at 30°C in LB media (10 g/l tryptone, 5 g/l yeast extract, 10 g/l NaCl), 9 
solidified with 12 g/l agar or supplemented with antibiotics (kanamycin, 100 μg/ml; streptomycin, 100 10 
μg/ml) where required. 11 
Fungal strains, plasmids and culture conditions 12 
Fungal strains and plasmids are given in Supplementary Table 2. To generate mutant strains of S. 13 
cerevisiae K699 carrying chromosomal insertions of GFP or bacterial effector genes under the control 14 
of the PGAL1 promoter, linearized plasmids pSC1384 (control), pSC1379 (GFP), pSC1382 (Tfe1) and 15 
pSC1380 (Tfe2), all based on plasmid pGED1, were integrated by allelic exchange into the HIS3 16 
locus. Plasmid-based gene expression utilised the galactose-inducible vector pRB1438. For in trans 17 
expression of bacterial effectors in C. albicans, chromosomal integration mutants based on the 18 
doxycycline-inducible expression vector pNIM118 were generated. To ensure correct leucine 19 
incorporation into the expressed protein in C. albicans, synthetic genes carrying CTG to TTG 20 
substitutions (Invitrogen) were subcloned into pNIM1. Correct sequence and locus integration was 21 
confirmed by sequencing of the respective PCR product, together with Southern blot analysis for C. 22 
albicans. All primer sequences for mutant and plasmid generation and Southern blot probe generation 23 
are given in Supplementary Table 3. Fungal strains were cultured at 30°C in YPA (10g/l yeast extract, 24 
20g/l peptone, 40 mg/l adenine hemisulfate) or synthetic complete (SC; 6.9 g/l yeast nitrogen base 25 
complete with ammonium sulfate and amino acids) media containing 2% glucose49. If utilizing 26 
auxotrophies, SC media lacking the respective amino acid or nucleotide was used. For induction of 27 
the PGAL1 promoter, S. cerevisiae cultures were pre-incubated in media containing 2% raffinose, 28 
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washed, and incubated with media containing both 2% galactose and 2% raffinose unless otherwise 1 
stated. Induction of the Tet-inducible promoter in C. albicans was by addition of 50 µg/ml 2 
doxycycline. 3 
Co-culture assay for T6SS-mediated anti-fungal activity 4 
Anti-fungal activity assays were based on the anti-bacterial co-culture assay described previously10. 5 
Both the attacker strain derived from S. marcescens Db10 and the respective fungal target strain were 6 
normalized to an OD600 of 1, mixed at a volume ratio of 1:1 (attacker:target cell ratio ~100:1), and 7 
12.5 µl of the mixture were spotted on solid SC + 2% glucose media and incubated for 7.5 h at 30°C. 8 
Surviving target fungal cells were enumerated by serial dilution and viable counts on streptomycin-9 
supplemented YPDA media. Co-culture assays for anti-bacterial activity were performed as 10 
described10, 16. For assessment of cell contact dependence, bacterial and fungal cells were separated by 11 
a membrane (pore size 0.22 µm), with the bacterial layer between the solid medium and the 12 
membrane and the fungal cells spotted on top of the membrane. S. cerevisiae grew equally well on the 13 
membrane placed on top of the bacterial cell layer compared with direct growth on the medium, 14 
confirming efficient diffusion of nutrients through the membrane. The co-culture experiments 15 
presented contain data from four independent biological replicates, performed on at least two days, 16 
with T6SS-dependent anti-fungal activity and the phenotypes of the Δtfe1 and Δtfe2 mutants having 17 
been confirmed on multiple independent occasions. 18 
Plate toxicity assay 19 
Fungal cells were pre-grown in non-inducing liquid minimal media (SC + 2% glucose, C. albicans; 20 
DOA-LEU + 2% raffinose, S. cerevisiae) at 30°C, adjusted to an OD600 of 1, serially diluted and 5 µl 21 
spotted onto minimal media agar. Heterologous protein expression was induced by addition of 22 
doxycyline (50 µg/ml, C. albicans) or galactose (0.008 – 0.2%, S. cerevisiae). Agar plates were 23 
incubated at 30°C and pictures taken after 48 h (C. albicans) or 96 h (S. cerevisiae). 24 
Cell morphology and viability analysis by microscopy  25 
Single cell morphology of fungal cells grown in co-culture (7.5 h) or in liquid induction media (SC + 26 
2% glucose + 50 µg/ml doxycycline, C. albicans; DOA-URA + 2% raffinose + 2% galactose, S. 27 
cerevisiae; 8h) was visualized by differential interference contrast (DIC) using a Axio-Imager M1 28 
15 
 
microscope equipped with a 100x objective, AxioCam MRm camera and ZEN software (Zeiss). The 1 
images presented show multiple individual cells from part of one field of view, for clarity, and are 2 
representative of between 9 and 42 fields of view, acquired on three separate occasions. To determine 3 
the percentage of PI-stained fungal cells, cells from three independent fungal-bacterial co-cultures 4 
grown at 30°C for 7.5 h on solid SC + 2% glucose media were recovered in 1x PBS and stained with 5 
PI at a final concentration of 10 µg/ml. Following a 15 min incubation at 30°C, 1.5 μl of the stained 6 
cell suspension were placed on a microscope slide layered with a 1% agarose pad and cells were 7 
detected by both DIC and fluorescence microscopy using a HBO 100 mercury lamp and appropriate 8 
filter sets (Ex 546/12 nm, Em 607/65 nm) and 40x objective. A minimum of 160 cells per 9 
experimental condition and replicate were scored, with the aid of the counting tool in 10 
OMERO.mtools50. Cells subjected to a 40 min heat-shock at 65°C served as positive control for PI 11 
staining. Visualisation of C. albicans hyphae was performed using a Zeiss Axioskop 2 MOT 12 
microscope, 63x objective, HBO100 mercury lamp and Zeiss Axiocam Color camera, following 13 
incubation with 1 µM propidium iodide for 10 min. Microscopy images were managed and processed 14 
according to accepted standards using OMERO (http://openmicroscopy.org)50 and Fiji51. 15 
Microscopy analysis of metabolic activity and membrane potential 16 
For staining of effector-expressing S. cerevisiae cells using FUN1, cells were grown in synthetic drop-17 
out media (DOA-LEU) supplemented with 2% raffinose, washed once, normalized to an OD600 of 0.5 18 
and expression induced by addition of 2% galactose for 9 h. Cells were washed, suspended in 10 mM 19 
HEPES, pH 7.2, 2% raffinose, 2% galactose, stained with FUN1 (Thermo Fisher, dilution 1:1;000) for 20 
30 min at 30°C, and analysed by DIC and fluorescence microscopy using appropriate filter sets (green, 21 
Ex 470/40 nm, Em 525/50 nm, 40 ms exposure; and red, Ex 546/12 nm, Em 607/65 nm, 150 ms 22 
exposure) on the Axio-Imager described above. Multiple fields of view were imaged and the experiment 23 
has been reproduced on an independent occasion.  24 
To visualise and distinguish between changes in plasma membrane potential and membrane diffusion 25 
barrier function, S. cerevisiae cells grown in liquid induction media (DOA-URA + 2% raffinose + 2% 26 
galactose; 6 h) were placed on a microscope slide layered with a 1% agarose pad containing the voltage-27 
dependent dye Bis-(1,3-dibutylbarbituric acid) trimethine oxonol [DiBAC4(3)] (AnaSpec) at a final 28 
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concentration of 10 µM, either alone, or combined with the membrane permeability-reporter propidium 1 
iodide (Sigma) added at a final concentration of 1 µM. To suppress binding of DiBAC4(3) on the glass 2 
surface, the coverslips were coated with L-dopamine52. Amphotericin B (Sigma), used as positive 3 
control to induce membrane depolarization without pore formation, was added to control cells at the 4 
start of the 6 h induction period at a final concentration of 3 µg/ml. The pore-forming peptide mellitin 5 
(AnaSpec) was added to the cells 10 min prior to the end of the 6 h induction period at a final 6 
concentration of 100 µM. Fluorescence and phase contrast microscopy was carried out with Nikon 7 
Eclipse Ti equipped with Nikon Plan Apo 100x/1.40 Oil Ph3 objective, Sutter Instrument Company 8 
Lambda LS xenon arc light source, and Photometrics Prime sCMOS camera using appropriate filter 9 
sets (green Ex 470/40 nm, Em 525/50 nm, 500 ms exposure; and red Ex 560/40 nm, 630/40 nm, 100 10 
ms exposure). The images were captured using Metamorph 7.7 (Molecular Devices). Multiple fields of 11 
view were imaged and the experiment has been reproduced on an independent occasion. The 12 
quantification of cell fluorescence levels was performed by automated detection of cells using phase 13 
contrast images, followed by measurement of whole cell DiBAC4(3) and Propidium iodide average 14 
fluorescence intensities from corresponding, background-subtracted fluorescent micrographs.  The cell 15 
detection and fluorescence intensity measurements were carried out using Fiji51. 16 
Immunoblot analysis 17 
Anti-Hcp and anti-Ssp2 immunoblots were performed on cultures grown for 5 h as previously 18 
described10, 16. Polyclonal anti-Hcp10 and anti-Ssp216 primary antibodies were used at 1:6,000 and 19 
1:2,000 respectively, with peroxidase-conjugated anti-rabbit secondary antibody (BioRad) at 20 
1:10,000. Cellular samples for immunodetection of GFP-Atg8 and Pgk1 were prepared from yeast-21 
bacterial co-cultures based on53. Yeast cells were harvested from co-cultures grown at 30°C for 7.5 h 22 
on solid SC + 2% glucose media into ice-cold phosphate buffered saline (PBS; 8 g/l NaCl, 0.2 g/l 23 
KCl, 1.42 g/l Na2HPO4, 0.24 g/l KH2PO4, pH 7.4), washed twice by filtering through 3 µm pore-sized 24 
PVDF membranes (Millipore) and recovered by centrifugation. For subsequent protein extraction, cell 25 
pellets were resuspended and incubated for 10 min in 0.2 M NaOH, 1% β-mercaptoethanol. Proteins 26 
were precipitated by addition of trichloroacetic acid (TCA; 20% final concentration), washed once in 27 
ice-cold acetone, resuspended in 2x SDS sample buffer (100 mM Tris-HCl, pH 6.8, 3.2% SDS, 3.2 28 
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mM EDTA, 16% glycerol, 0.2 mg/ml bromophenol blue and 2.5% β-mercaptoethanol) and boiled for 1 
10 min before being subjected to western blot analysis. Due to the growth impediment of S. cerevisiae 2 
in the presence of S. marcescens Db10 and residual bacterial contamination of yeast samples, protein 3 
extracts were normalized according to the abundance of the protein Pgk1. Monoclonal anti-GFP (cat # 4 
11814460001, Roche) and polyclonal anti-Pgk1 (cat # 13472727, Invitrogen) primary antibodies were 5 
used at 1:5,000 and 1:1,000 respectively, with peroxidase-conjugated anti-mouse and anti-rabbit 6 
secondary antibodies (BioRad) at 1:10,000.  7 
Quantitative real-time PCR 8 
RNA was extracted from three independent cultures of control and Tfe2-expressing S. cerevisiae 9 
cells, induced for 6 h at 30°C in galactose induction media, using the SV Total RNA Isolation System 10 
(Promega), followed by treatment with the Turbo DNA-free kit (Ambion) to remove residual gDNA. 11 
RNA was reverse transcribed using the iScript cDNA Synthesis Kit (Bio-Rad) and relative levels of 12 
cDNA determined using an Mx3005P QPCR machine (Stratagene, Agilent Technologies) with actin 13 
(ACT1) as the normalizing gene. Primer sequences are given in Supplementary Table 3. The 14 
experiment presented has been reproduced on an independent occasion. 15 
Whole-cell amino acid analysis 16 
Three independent cultures of control and Tfe2-expressing S. cerevisiae cells were incubated for 6 h 17 
at 30°C in galactose induction media, washed twice with ice-cold water, normalized to 5 OD600 per 1 18 
ml of water and boiled for 15 min. After centrifugation, the supernatant was clarified using a 0.2 µm 19 
syringe filter (Sartorius). The resulting extract was acidified by addition of TFA in MeOH (10%, v/v), 20 
dried and resuspended in buffer (40% 1M NaOAc, 40% MeOH, 20% triethylamine, TEA), before 21 
being dried again. The amino acids were then derivatized using Phenylisothiocyanate (PITC) by 22 
resuspension of the dried material in 10% PITC, 70% MeOH, 10% H2O, 10% TEA, followed by 2-23 
fold dilution in MeOH. After 15 min incubation at room temperature, suspensions were dried, washed 24 
once with MeOH and suspended in elution buffer, composed of 95% (150 mM NaOAc, 0.5 ml/l TEA, 25 
pH 6.4) and 5% acetonitrile. PTC amino acid derivatives were analysed by HPLC using a Nova-Pak® 26 
C18 column (Waters), the Clarity Lite software and two amino acid standard sets (AA-S-18 and 27 
A6282, Sigma). The experiment presented has been reproduced on two independent occasions. 28 
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Sample preparation for mass spectrometry 1 
For analysis of the cellular proteome of S. marcescens, six biological replicates of each strain (two 2 
spots of 25 µl of OD600 0.5 per replicate) were grown on solid LB media for 7.5 h at 30°C. Cells were 3 
recovered, washed in ice-cold PBS, resuspended in 1% sodium 3-[(2-methyl-2-undecyl-1,3-dioxolan-4 
4-yl)methoxy]-1-propanesulfonate (commercially available as RapiGest, Waters, Milford, MA), 50 5 
mM Tris-HCl pH 8.0, 1 mM tris(2-carboxyethyl)phosphine (TCEP) and lysed by sonication.  6 
For analysis of bacterially-intoxicated fungal cells, co-cultures of C. albicans and S. marcescens (57 7 
co-culture spots, inoculated as above, per replicate) were incubated on solid SC + 2% glucose media 8 
for 4 h at 30°C, with six biological replicates per combination. Cells were harvested in 40 ml ice-cold 9 
PBS, washed 2x by filtration using PVDF membranes, pore size 3 µm (Millipore), suspended in PBS 10 
and recovered by centrifugation. Cells were sonicated in 1% Rapigest, 50 mM Tris-HCl pH 8.0, 1 11 
mM TCEP in the presence of 0.1 mm zirconia/silica beads (BioSpec) for 6x 10 sec with 20 sec 12 
intervals. In each study, following sonication, samples were heated for 5 min at 95°C and soluble 13 
protein extracts recovered by centrifugation.  14 
Protein concentrations were determined using the EZQ Kit (Thermo-Fisher Scientific) and cysteines 15 
were alkylated by addition of 5 mM iodoacetamide. After 20 min incubation in the dark at 25°C, the 16 
reaction was quenched by addition of 5 mM DTT and samples were diluted 10x in 50 mM Tris-HCl 17 
pH 8.0. Digestion of proteins was by addition of trypsin (MS grade, Pierce, Thermo-Fisher) at a 1:150 18 
(w/w) ratio with incubation overnight at 37°C, followed by a second addition of trypsin (1:150 w/w) 19 
with 3 h incubation. Rapigest was cleaved by addition of 2% trifluoroacetic acid (TFA) and 20 
incubation for 1 h at 37°C. Samples were desalted using C18 columns (Harvard Apparatus) and 21 
lyophilised.  22 
Mass spectrometry analysis of Serratia marcescens cellular proteome 23 
Lyophilised peptide samples (six biological replicates) were taken up in 2% acetonitrile (ACN), 0.1% 24 
TFA and analysed similar to previously published methods54-56: separated on an Ultimate 3000 RSLC 25 
system (Thermo-Fisher Scientific) with a C18 PepMap, serving as a trapping column (2 cm x 100 µm 26 
ID, PepMap C18, 5 µm particles, 100 Å pore size) followed by a 50 cm EASY-Spray column (50 cm 27 
x 75 µm ID, PepMap C18, 2 µm particles, 100 Å pore size; Thermo-Fisher Scientific) with a 6 h 28 
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gradient consisting of 3-30% B (B= 80% ACN, 0.1% formic acid (FA); 10-260 min), to 40% B (330 1 
min), 99% B (335-345 min), 3% (350-360 min) at 300 nl/min. Mass spectrometric identification and 2 
quantification was performed on an Orbitrap Velos mass spectrometer (Thermo-Fisher Scientific) 3 
operated in data dependent, positive ion mode. FullScan spectra were acquired in a range from 350 4 
m/z to 1600 m/z, at a resolution of 60,000. MS/MS in the ion trap was triggered for ions above 2000 5 
with a maximum injection time of 10 ms for the 20 most intense precursor ions in RapidScan and a 6 
lockmass of 445.120024. Collision-induced dissociation (CID) fragmentation was performed at a 7 
collision energy of 35% and 0.25 activation Q.  8 
Label-free protein identification and quantification were performed using MaxQuant version 1.4.1.257 9 
with the following parameters: stable modification carbamidomethyl (C); variable modifications 10 
oxidation (M), acetylation (protein N terminus), and trypsin as enzyme with 2 missed cleavages. 11 
Search was conducted using a combined FASTA database of Serratia marcescens Db11 and the 12 
Uniprot Homo sapiens database (downloaded May 1st 2013), including common contaminants. Mass 13 
accuracy was set to 4.5 ppm for precursor ions and 0.5 Da for ion trap MS/MS data. Identifications 14 
were filtered at a 1% false-discovery rate (FDR) at the protein and peptide level, accepting a 15 
minimum peptide length of 7 amino acids. Quantification of identified proteins referred to razor and 16 
unique peptides, and required a minimum ratio count of 2. Normalized ratios were extracted for each 17 
protein and were used for downstream analyses. 18 
‘In competition’ proteomics of bacterially-intoxicated C. albicans 19 
Isobaric labelling of peptides was performed using 6-plex tandem mass tag (TMT) reagents (Thermo-20 
Fisher Scientific). TMT reagents (0.8 mg) were dissolved in 40 μl of acetonitrile and 20 μl was added 21 
to six biological replicates of lyophilised peptide samples, previously dissolved in 50 μl of 50 mM 22 
triethylammonium bicarbonate, pH 8.0. The individual samples of the strains were labelled as follows 23 
for all six replicates: WT, 126; ΔtssE, 127; Δtfe1, 128; Δtfe2, 129; Δtfe1Δtfe2, 130. After labelling, 24 
the reaction was quenched by addition of 4 μl of 5% hydroxylamine after 1 hour incubation at room 25 
temperature. Individual samples were tested for labelling efficiency (>95%) before the labelled 26 
peptides were combined, acidified with 0.1% TFA and concentrated using C18 SPE on Sep-Pak 27 
cartridges (Waters). Equal loading of all five conditions was confirmed by the majority of peptide 28 
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intensities not changing before normalisation.  1 
TMT labelled peptides were subjected to hydrophilic Strong Anion Exchange (hSAX) fractionation.58 2 
Labelled peptides were solubilized in 20 mM Tris-HCl, pH 10.0) and separated on a Dionex RFIC 3 
IonPac AS24 column (IonPac series, 2 × 250 mm, 2000 Å pore size; Thermo-Fisher Scientific). Using 4 
a DGP-3600BM pump system equipped with a SRD-3600 degasser (Thermo-Fisher Scientific) a 30 5 
min gradient length from 8% to 80% of 1M NaCl in 20 mM Tris-HCl, pH 10 (flow rate of 0.25 6 
ml/min), separated the peptide mixtures into a total of 34 fractions. The 34 fractions were merged into 7 
9 samples, acidified with 1 %TFA (pH = 2), desalted via C18 Macro SpinColumns (Harvard 8 
Apparatus), dried under vacuum centrifugation and re-suspended in 2% ACN / 0.1% TFA for LC-9 
MS/MS analysis. 10 
Peptide samples were separated on an Ultimate 3000 RSLC system with a C18 PepMap, serving as a 11 
trapping column (2 cm x 100 µm ID, PepMap C18, 5 µm particles, 100 Å pore size) followed by a 50 12 
cm EASY-Spray column with a linear gradient consisting of (2.4-28% ACN, 0.1% FA) over 150 min 13 
at 300 nl/min. Mass spectrometric identification and quantification was performed on an Orbitrap 14 
Fusion Tribrid mass spectrometer (Thermo-Fisher Scientific) operated in data dependent, positive ion 15 
mode. FullScan spectra were acquired in a range from 400 m/z to 1500 m/z, at a resolution of 16 
120,000, with an automated gain control (AGC) of 300,000 ions and a maximum injection time of 50 17 
ms. The 12 most intense precursor ions were isolated with a quadrupole mass filter width of 1.6 m/z 18 
and CID fragmentation was performed in one-step collision energy of 32% and 0.25 activation Q. 19 
Detection of MS/MS fragments was acquired in the linear ion trap in a rapid mode with an AGC 20 
target of 10,000 ions and a maximum injection time of 40 ms. Quantitative analysis of TMT-tagged 21 
peptides was performed using FTMS3 acquisition in the Orbitrap mass analyser operated at 60,000 22 
resolution, with an AGC target of 100,000 ions and maximum injection time of 120 ms. Higher-23 
energy C-trap dissociation (HCD fragmentation) on MS/MS fragments was performed in one-step 24 
collision energy of 55% to ensure maximal TMT reporter ion yield and synchronous-precursor-25 
selection (SPS) was enabled to include 10 MS/MS fragment ions in the FTMS3 scan. 26 
Protein identification and quantification were performed using MaxQuant version 1.5.1.757 with the 27 
following parameters: stable modification carbamidomethyl (C); variable modifications oxidation 28 
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(M), acetylation (protein N terminus), deamidation (NQ), hydroxyproline (P), quantitation labels with 1 
6plex TMT on N-terminal or lysine with a reporter mass tolerance of 0.01 Da and trypsin as enzyme 2 
with 2 missed cleavages. Search was conducted using a combined FASTA database of Serratia 3 
marcescens Db11 and the Candida albicans SC5314 (assembly 22) database59 (downloaded from 4 
www.candidagenome.org on September 1st 2015), including common contaminants. Mass accuracy 5 
was set to 4.5 ppm for precursor ions and 0.5 Da for ion trap MS/MS data. Identifications were 6 
filtered at a 1% FDR at the protein and peptide level, accepting a minimum peptide length of 7 amino 7 
acids. Quantification of identified proteins referred to razor and unique peptides, and required a 8 
minimum ratio count of 2. Normalized ratios were extracted for each protein/conditions and were 9 
used for downstream analyses.  10 
Mass spectrometry data analysis 11 
Data was further analysed using the Perseus software package60. Pairwise comparisons were made 12 
using Student’s T-tests (p<0.05, two-tailed). Multiple samples were analysed using ANOVA at 13 
p<0.05. Perseus was also used for heatmaps and clustering (Euclidean, 10 clusters) of ANOVA 14 
positive proteins. For the S. marcescens cellular proteome, proteins were identified as differentially 15 
abundant when at least two unique peptides were identified, intensities were detected in a minimum of 16 
two out of the six biological replicates, and average LFQ intensities were altered more than 1.4-fold 17 
(|log2| > 0.5, p-value < 0.05). For the bacterially-intoxicated C. albicans proteome, modulated 18 
proteins had significant ANOVA score (two-sided, p-value < 0.05) and strong effector-specific 19 
changes were identified by pairwise comparison (fold change >1.3, p-value < 0.05). Gene Ontology 20 
(GO) term analysis was carried out using the GO Term Finder Tool applying standard settings 21 
available at Candida Genome Database (CGD)61 (http://www.candidagenome.org/). 22 
Data availability 23 
Raw mass spectrometry data that support the findings of this study have been deposited to the 24 
ProteomeXchange Consortium via the PRIDE62 partner repository with the dataset identifier 25 
PXD006916. All other data supporting the findings of this study are available within the paper and its 26 
supplementary information files.  27 
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Figure 1. Cross-kingdom targeting by the Type VI secretion system of S. marcescens depends on the anti-
fungal effectors Tfe1 and Tfe2. (a) Number of recovered viable cells of S. cerevisiae K699 following co-culture 
with wild type (WT) or a T6SS-inactive mutant (ΔtssE) strain of S. marcescens Db10 as attacker, or with sterile 
media alone (media), in the absence or presence of a separating membrane. (b) Recovery of C. albicans SC5314 
and C. glabrata ATCC2001 following co-culture with wild type or a T6SS-inactive mutant of S. marcescens. (c) 
Recovery of C. albicans, left, S. cerevisiae, middle, and C. glabrata, right, following co-culture with wild type or 
mutant (ΔtssE, Δtfe1, Δtfe2, Δtfe1Δtfe2 and ΔSMDB11_3457) S. marcescens. (d) Recovery of C. albicans, S. 
cerevisiae and C. glabrata following co-culture with wild type or mutant strains of S. marcescens Db10 carrying 
either the vector control plasmid (+VC, pSUPROM), or a plasmid directing the expression of Tfe1 with the 
immunity protein Sip3 (+Tfe1), or Tfe2 (+Tfe2). (e) Immunoblot detection of Hcp1 and Ssp2 in cellular and 
secreted fractions of wild type or mutant S. marcescens as indicated. In parts a-d, individual data points are 
overlaid with the mean +/- SEM (n=4 biological replicates). 
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Figure 2. Quantitative cellular proteomics identifies known and new T6SS-secreted proteins. (a) Volcano 
plot summarising the proteomic comparison of total intracellular proteins between the wild type (WT) and a T6SS-
inactive mutant (ΔtssE) strain of S. marcescens Db10 using label-free quantitation. The log2 of the ratios of protein 
intensities between the wild type and the ΔtssE mutant are plotted against the –log10 of t-test p-values. Proteins 
significantly increased in abundance in the ΔtssE mutant compared with the wild type (ΔtssE/WT > 1.4-fold; p < 
0.05) are depicted as circles, with magenta circles representing those secreted effectors (SE) identified as new 
anti-fungal effectors in this study, and blue circles representing other hits, including secreted core components 
(SCC) or previously identified secreted effectors. Grey squares represent proteins significantly decreased in 
abundance in the ΔtssE mutant compared with the wild type (ΔtssE/WT < -1.4-fold; p < 0.05) and black diamonds 
correspond to proteins without significant changes. Numbers in brackets represent genomic identifiers for the 
proteins (SMDB11_xxxx). (b) Schematic depiction of the genetic loci containing the tfe1, tfe2 and SMDB11_3457 
genes in S. marcescens Db10. The sip3 gene encodes the previously identified immunity protein for Tfe1/Ssp3.  
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Figure 3. Tfe1 and Tfe2 are anti-fungal toxins with a species-specific impact on fungal cell integrity. (a) DIC 
microscopy of target strains C. albicans SC5314, S. cerevisiae K699 and C. glabrata ATCC2001, following co-
culture with wild type or mutant (ΔtssE, Δtfe1, Δtfe2, Δtfe1Δtfe2) strains of S. marcescens Db10. ‘None’ indicates 
co-culture of the target with media alone. (b) Percentage of live fungal cells of C. albicans, C. glabrata and S. 
cerevisiae, following co-culture with strains of S. marcescens, as indicated by propidium iodide (PI) staining. Bars 
show mean +/- SEM (n=3 independent experiments, with individual data points shown). (c) DIC microscopy of 
C. albicans SC5314 (control) and derivatives expressing GFP, Tfe1 or Tfe2, upper panel, and S. cerevisiae K699 
carrying the control plasmid pRB1438 or GFP-, Tfe1- or Tfe2-expression plasmids, lower panel. (d) Growth of 
S. cerevisiae K699 chromosomal integration strains harbouring the empty promoter construct (control) or 
constructs for expression of GFP, Tfe1 or Tfe2, on non-inducing and inducing media (gal, galactose).  
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Figure 4. T6SS-mediated effector delivery disrupts fungal metabolic activity and membrane potential, and 
can act against hyphal cells. (a) Growth of S. cerevisiae expressing Tfe2 as determined by cell density (OD600) 
and viable cell counts (cfu/ml). Time-course presented includes an induction period in non-inducing (none, 2% 
raffinose) or inducing media (induce, 2% raffinose 2% galactose), followed by either relief (none, 2% raffinose), 
repression (repress, 2% raffinose 2% glucose) or ongoing (induce, 2% raffinose 2% galactose) expression of Tfe2. 
Points show mean +/- SEM (n=3). (b) Fluorescence microscopy of FUN1-stained S. cerevisiae cells expressing 
GFP, Tfe1 or Tfe2. The single and merged green and red fluorescence channels, and their overlays on the 
corresponding DIC image are shown. (c) Quantification of fluorescence from S. cerevisiae cells expressing Tfe1 
or Tfe2, following staining with the potential-sensitive dye DiBAC4(3). Control cells were additionally treated 
with 100 µM mellitin (membrane depolarization through pore formation) or 3 µg/ml amphotericin B (membrane 
depolarization without pore formation). Points represent individual cells and bars show mean (ns, not significant; 
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** p<0.01; *** p<0.001; unpaired t-test). (d) Quantification of cellular DiBAC4(3) and propidium iodide (PI) 
fluorescence for cells expressing Tfe1 or Tfe2, or treated with mellitin or amphotericin B. Scatter plots depict 
fluorescence intensity values of individual cells for both dyes (au, arbitary units); Example microscopy images  
and separate scatter plots are in Supplementary Fig. 7. (a)-(d) S. cerevisiae strains were K699 chromosomal 
integration strains harbouring the empty promoter construct (control) or constructs for galactose-inducible 
expression of GFP, Tfe1 or Tfe2. (e) Representative images and (f) quantification of PI staining of hyphae of the 
constitutively filamentous tup1Δ mutant of C. albicans, following co-culture with the strains of S. marcescens 
Db10 indicated (none, media only; WT, wild type). Bars show mean +/- SEM (n=3 independent experiments, 
individual data points shown). 
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Figure 5. ‘In competition’ quantitative proteomics reveals interference of Tfe2 with fungal nutrient uptake 
and metabolism. (a) Heat map showing hierarchical clustering of the differential proteome of C. albicans SC5314 
following co-culture with wild type S. marcescens Db10 compared with mutant (ΔtssE, Δtfe1, Δtfe2 and 
Δtfe1Δtfe2) strains of Db10. All proteins with significant ANOVA scores (p<0.05) are included and the full cluster 
analysis with gene identifiers is available as Supplementary Data 3. (b) GO terms significantly enriched (p<0.05) 
in the set of C. albicans SC5314 proteins identified as significantly responsive to Tfe2 (Supplementary Table 1). 
Where different, the protein name in S. cerevisiae is given in brackets. (c,d) Schematic illustration (left panels) 
and corresponding heat-maps of the pathway-associated proteins (right panels) of the sulfate assimilation and 
arginine biosynthesis  pathways in fungal cells. Proteins increased in abundance following co-culture with wild 
type S. marcescens as compared with the mutant strains indicated are shown in purple, and proteins decreased are 
shown in orange.  
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Figure 6. Tfe2 alters the cellular amino acid pool and induces autophagy in fungal cells. (a) Relative levels 
of total intracellular amino acids in S. cerevisiae K699 expressing plasmid-borne Tfe2 (+Tfe2) compared with the 
vector control (Cit, citrulline; Orn, ornithine). Bars show log2 of the mean +/- SEM (n=3 biological replicates), 
with individual data points shown. (b) Differential expression analysis of genes involved in nutrient sensing and 
starvation in S. cerevisiae expressing Tfe2 relative to the vector control. qRT-PCR analysis was performed on 
transcripts of genes for amino acid permease and dipeptide transporters that are under the control of the amino 
acid sensor complex SPS (AGP1, GNP1, BAP2, BAP3, DIP5, CAN1, PTR2), the SPS sensor component (SSY1), 
the SPS-activated transcriptional regulators (STP1, STP2), the sulfate transporter (SUL1, SUL2) and the general 
amino acid control response regulator (GCN4). Bars show log2 of the mean relative transcript abundance +/- SEM 
(n=3 biological replicates). (c) Immunoblot detection of GFP-Atg8 processing in S. cerevisiae K699 following 
co-culture with wild type (WT) or mutant (ΔtssE and Δtfe2) strains of S. marcescens Db10 using anti-GFP 
antibody. Yeast cells carry the reporter plasmid GFP-ATG8(416) directing expression of GFP-Atg8 from the 
endogenous Atg8 promoter. GFP-Atg8 has a MW of 41 kDa and cleaved GFP is 27 kDa. Pgk1 was used as control 
cellular protein and dashed line indicates where the blot membrane was cut to allow detection with the two 
different antibodies. 
